Cluster page — medicines optimisation

The PCN MO dashboard

Exactly the KPIs the Clinical Director should hold, where they come from, and how they roll up to the ICB.

Dashboard structure

Four KPI families — every one earns its row

The PCN MO dashboard does one job: give the Clinical Director a single-page view of whether the network is delivering safe, evidence-based, cost-effective and DES-compliant medicines optimisation. It is not a comprehensive metric dump; it is the small set of measures that drive the next month's priority. Four families cover it: clinical activity, prescribing safety, cost, and DES assurance.

Every BCS-supplied PCN receives a Power BI / Excel variant of this dashboard, refreshed monthly from EMIS/SystmOne, ePACT2 and the supervision log, and reviewed jointly with the Clinical Director.

Clinical activity KPIs

What good activity looks like

  • SMRs completed YTD vs DES cohort target (cumulative and monthly)
  • HRD register patients with current monitoring (%)
  • Discharge reconciliation completion within 7 days (%)
  • Deprescribing actions per SMR (mean)
  • LTC titration clinic throughput (HTN, T2DM, lipids, respiratory)

Prescribing safety KPIs

Safety dashboard rows

  • MHRA Class 1/2 alert closure within window (%)
  • PINCER hazard search interventions completed per quarter
  • SEAs raised, completed and themed (count + theme map)
  • Prescribing safety incident rate per 10k patients
  • Prescribing safety culture audit score (annual)

Cost & DES KPIs

Cost and assurance

  • Prescribing cost per weighted patient vs ICB peer median
  • Formulary first-line rate on new starts (%)
  • Switch programme completion against schedule (%)
  • Supervision evidence currency for every ARRS role (%)
  • Scope of practice currency for every ARRS role (%)

Frequently asked questions

MO KPIs — FAQs

What MO KPIs should a PCN Clinical Director hold?+

Four families: clinical activity (SMRs, HRD reviews, reconciliation rate, deprescribing), prescribing safety (MHRA alert closure, PINCER intervention, SEA volume and themes), cost outcomes (prescribing cost per weighted patient, formulary first-line rate, switch programme completion), and DES assurance (supervision evidence, scope of practice currency, cohort delivery against target).

How often should the dashboard be reviewed?+

Monthly at PCN management meeting, quarterly with ICB MO team. The Lead Pharmacist owns dashboard production; the Clinical Director owns review and action.

What data sources feed the dashboard?+

EMIS/SystmOne SNOMED activity extract, ePACT2 and OpenPrescribing prescribing data, MHRA alert log, PINCER outputs, SEA register, supervision log, and the workforce HR record.

How is dashboard data presented to the ICB?+

Quarterly via the ICB MO return template — cohort delivery, exception narrative, prescribing safety summary, cost outcome and supervision evidence. Most ICBs now publish PCN-comparator dashboards back to the network.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call